Dan O’Korn is a partner with Hutchinson Law, where his practice focuses on the business transactions important to pharmaceutical and biotech companies, including licensing and commercial transactions, FDA-related regulatory matters, asset acquisitions and divestitures, supply agreements, product development agreements, and strategic alliances.
Dan previously served as outside counsel to life sciences companies and in in-house counsel roles for Eli Lilly and Company; AAIPharma, Inc.; Xanodyne Pharmaceuticals, Inc.; and Xcellerex, Inc.
He graduated summa cum laude from Indiana University School of Law and earned his bachelor’s degree from Wabash College.